This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Arcturus Remove Invest Remove Marketing Related Topics
Equity Blogging Pricing Venture Capital Capital Services Startup Truecar Anthem Santa Monica More Related Topics >
article thumbnail

TrueCar Prices IPO

socalTECH

MAY 16, 2014

TrueCar is trading on the NASDAQ Global Select Market as TRUE. TrueCar is venture backed by backed by USAA, Capricorn Investment Group, Upfront Ventures, Anthem Ventures, Vulcan Capital Growth Equity, Peppy Capital Partners, Arcturus Venture Capital, along with others. The company raised around $71.1M in the IPO offering.

Truecar 147
Truecar Pricing Arcturus Anthem 147
article thumbnail

Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

Xconomy

MARCH 30, 2018

The strength of the IPO market is notable because the first quarter is typically the slowest time of the year for companies to go public, EY told Xconomy. The number of companies filing to go public in the U.S. Life science companies accounted for nearly one third of the quarter’s IPOs.

Activity 52
Activity Report Marketing Company 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024